+1803294983432
customer.service@microbix.com
Other Infectious Disease Antigen Products
Other antigen products to widen your portfolio.
Products
| Product Name | Catalogue Number | Description |
| Borrelia Burgdorferi | EL-24-02 | Description:Borrelia Burgdorferi native antigen is isolated from the B31 strain cultured in BSK 11 medium. Strain: B31 Buffer: PBS with magnesium
|
| Rotavirus Grade 3 | EL-35-03 | Description: Rotavirus native antigen is isolated from cultured MA104 cells that were infected with the Simian rotavirus SA11 strain. Strain: Simian rotavirusSAll, ICW 00.060.0.03.001.00.201.001 Buffer: MA1O4 cells
|
Download Our Full Product Catalogue
Frequently Asked Questions
What other infectious disease antigens do you offer?
Borrelia burgdorferi and rotavirus Grade 3.
Do your infectious disease antigens target specific strains or variants of pathogens?
Yes.
Do you provide antigens that are optimized for research versus clinical diagnostics?
Research use only, or for further manufacturing use (e.g. raw material use).
What is the shelf life of your infectious disease antigen products?
Guaranteed two years of stability from shipment date.
Testimonials
Proudly Supporting Over 100+ Customers with Leading Diagnostic Solutions
Learn more about how our clients worldwide use Microbix’s product lines to enhance the way they do business.
We considered other external quality controls but selected Microbix QAPs as the best solution to support assay optimization and to significantly simplify QC procedures with minimal to no pipetting steps. Microbix’s technical expertise, product design, performance, and superior customer service are impressive. We look forward to continuing our collaboration.
Robert Martinez, VP of Business Development & Scientific Affairs
We were looking for a set of controls that fully covered the range of high-risk HPV types and Microbix is the only company to have such a portfolio. After an extensive evaluation process, we concluded the performance of Microbix QAPs are exactly what Ulisse needs and the interactions with their team are delightful.
Bruna Marini, COO
MDx testing for HPV improves cervical cancer screening by identifying those at-risk efficiently. Close monitoring of the entire HPV testing workflow is critical to realizing this healthcare goal and Microbix’s HPV QAPs have been selected to support the quality assessment monitoring of the molecular testing process, a vital part of BVO’s quality management system
Dr. Rob Schuurman, National Reference Officer for the Dutch Cervical Cancer Screening Program (BVO)
r-Biopharm is pleased that the program will be delivering world-class diagnostic testing to some of the most remote populations in Australia. It has been a privilege to work with the program’s operational team and Microbix to integrate the use of the best possible test and test-workflow controls into the program
Andreas Simons, Director, Project Management Clinical Diagnostics
We’re pleased to be employing Microbix’s innovative QAPs for this new and important EQA program. Genital ulcers are the cause of a considerable and growing burden of disease that can only be alleviated by way of accurate diagnosis and treatment
Juha Wahlstedt, Sales Director at Labquality
Microbix approached us before the pandemic started, and the relationship developed so easily and quickly that we formalized our collaboration in 2020. Along with their excellent technical capabilities, they have successfully developed relationships with many diagnostics manufacturers around the world. We are pleased that our FLOQSwabs® are their exclusive choice for their growing line of swab formatted QAPs™.
Gaetano Natale, Chief Commercial Officer.
We’ve been using Microbix’s External Quality controls for 3 years specifically from their Respiratory and Sexually Transmitted Infections panels on our instruments. It has helped us ensure accurate and reliable patient results and we’ve been delighted with their performance.
Alfie Zhen Fang, Buyer, Procurement
Your Trusted Source for Infectious Disease Antigen Controls
Our other antigens portfolio for infectious diseases includes Borrelia burgdorferi and rotavirus Grade 3.
The Borrelia burgdorferi native antigen is isolated from the B31 strain cultured in BSK 11 medium.
The rotavirus native antigen is isolated from cultured MA104 cells that were infected with the Simian rotavirus SA11 strain.
Speak to an Infectious Disease Antigen Customer Service Representative
Let our knowledgeable experts help you secure your native infectious disease antigens today.
News & Insights from Our Diagnostics Experts
Microbix Reports Record Product Sales for Q4 and Fiscal 2024
reports results for its fiscal year and fourth quarter ended September 30, 2024 (“2024” and “Q4”) with record revenues, reflective of ongoing progress to increase sales from its diagnostic-test related ...
Microbix Schedules Release of Results for Q4 Fiscal 2024
announces that it expects to file the financial statements and management disclosure and analysis for its fourth quarter of fiscal 2024 ended September 30, 2024 (“Q4 2024”) prior to the start of trading on ...
Microbix Assisting EMQN with Novel Genetic-Test EQA Program
with EMQN announce the go-live of a program to support the accurate identification of patients who carry a gene-variant associated with increased susceptibility to hearing loss following treatment with a widely...